Vitamin D receptor and binding protein genes variants in patients with migraine.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
20
07
2023
received:
13
05
2023
accepted:
22
07
2023
medline:
23
10
2023
pubmed:
9
8
2023
entrez:
9
8
2023
Statut:
ppublish
Résumé
Several studies have shown a relationship between vitamin D and migraine, including the association between decreased serum 25-hydroxyvitamin D in patients with migraine and the positive effects of vitamin D supplementations in the therapy of this disease. Two single-nucleotide variants (SNVs) vitamin D receptor (VDR) gene, VDR rs2228570, and VDR rs731236 have shown an association with migraine risk in a previous case-control association study, while an exome sequencing study identified a rare variant in GC vitamin D binding protein gene. This study aims to look for the association between several common variants in these two genes and the risk for migraine. We genotyped 290 patients diagnosed with migraine and 300 age-matched controls using specific TaqMan assays for VDR rs2228570, VDR rs731236, VDR rs7975232, VDR rs739837, VDR rs78783628, GC rs7041, and GC rs4588 SNVs. We did not find an association between these SNVs and the risk for migraine. None of these SNVs were related to the positivity of a family history of migraine or with the presence of aura. The VDR rs731236A allele showed a significant association with the triggering of migraine attacks by ethanol (Pc = 0.007). In summary, the results of the current study suggest a lack of association between common SNVs in the VDR and GC gene and the risk of developing migraine. The possible relationship between VDR rs731236 and the triggering of migraine episodes with ethanol deserves future studies.
Sections du résumé
BACKGROUND/OBJECTIVES
Several studies have shown a relationship between vitamin D and migraine, including the association between decreased serum 25-hydroxyvitamin D in patients with migraine and the positive effects of vitamin D supplementations in the therapy of this disease. Two single-nucleotide variants (SNVs) vitamin D receptor (VDR) gene, VDR rs2228570, and VDR rs731236 have shown an association with migraine risk in a previous case-control association study, while an exome sequencing study identified a rare variant in GC vitamin D binding protein gene. This study aims to look for the association between several common variants in these two genes and the risk for migraine.
METHODS
We genotyped 290 patients diagnosed with migraine and 300 age-matched controls using specific TaqMan assays for VDR rs2228570, VDR rs731236, VDR rs7975232, VDR rs739837, VDR rs78783628, GC rs7041, and GC rs4588 SNVs.
RESULTS
We did not find an association between these SNVs and the risk for migraine. None of these SNVs were related to the positivity of a family history of migraine or with the presence of aura. The VDR rs731236A allele showed a significant association with the triggering of migraine attacks by ethanol (Pc = 0.007).
CONCLUSIONS
In summary, the results of the current study suggest a lack of association between common SNVs in the VDR and GC gene and the risk of developing migraine. The possible relationship between VDR rs731236 and the triggering of migraine episodes with ethanol deserves future studies.
Identifiants
pubmed: 37553799
doi: 10.1002/acn3.51872
pmc: PMC10578880
doi:
Substances chimiques
Receptors, Calcitriol
0
Vitamin D
1406-16-2
Ethanol
3K9958V90M
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1824-1832Informations de copyright
© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Am J Hum Genet. 2020 Mar 5;106(3):327-337
pubmed: 32059762
J Clin Neurol. 2018 Jul;14(3):366-373
pubmed: 29971976
J Neurol. 2010 Sep;257(9):1482-5
pubmed: 20407783
Am J Emerg Med. 2021 Dec;50:784-788
pubmed: 34879503
Neurosci Lett. 2020 Feb 16;720:134778
pubmed: 31978499
Nat Commun. 2020 Apr 2;11(1):1647
pubmed: 32242144
Ann Neurol. 2015 Dec;78(6):970-81
pubmed: 26418341
Neuromolecular Med. 2017 Mar;19(1):24-40
pubmed: 27282160
Headache. 2018 Nov;58(10):1530-1540
pubmed: 30341768
Cephalalgia. 2015 Aug;35(9):757-66
pubmed: 25424706
J Neurol. 2021 Apr;268(4):1461-1472
pubmed: 33219423
Headache. 2010 Jan;50(1):85-91
pubmed: 19486361
Headache. 2008 Oct;48(9):1343-8
pubmed: 18266724
J Neurol Sci. 2014 Mar 15;338(1-2):92-5
pubmed: 24412224
Headache. 2015 Feb;55(2):276-86
pubmed: 25612138
Neurol Sci. 2020 May;41(5):1183-1192
pubmed: 31897949
J Res Med Sci. 2013 Mar;18(Suppl 1):S66-70
pubmed: 23961291
Front Nutr. 2022 Jul 08;9:907789
pubmed: 36159496
Pharmacogenomics J. 2020 Jun;20(3):426-432
pubmed: 31792366
Front Neurol. 2021 Feb 09;12:604052
pubmed: 33633666
Eur J Neurol. 2010 Sep;17(9):1220-1223
pubmed: 20236178
Biochem Biophys Res Commun. 2015 Jan 9;456(2):631-6
pubmed: 25498546
J Res Med Sci. 2015 May;20(5):477-82
pubmed: 26487877
Antioxidants (Basel). 2022 May 30;11(6):
pubmed: 35739987
Int J Environ Res Public Health. 2015 Oct 30;12(11):13913-22
pubmed: 26528998
Aging Clin Exp Res. 2020 Jan;32(1):21-27
pubmed: 30863943
Headache. 2012 Nov-Dec;52(10):1499-505
pubmed: 22973803
Eur J Clin Invest. 2022 Jun;52(6):e13757
pubmed: 35113457
Int J Mol Sci. 2023 Jan 09;24(2):
pubmed: 36674807
BMJ. 1994 Jul 9;309(6947):102
pubmed: 8038641
PLoS One. 2014 Aug 22;9(8):e105319
pubmed: 25147936
Mol Neurobiol. 2022 Jun;59(6):3458-3466
pubmed: 35322382
Rev Neurol (Paris). 2020 Sep;176(7-8):560-570
pubmed: 32241571
BMC Neurol. 2019 May 15;19(1):99
pubmed: 31092216
J Neuroimmunol. 2017 Apr 15;305:92-95
pubmed: 28284354
J Neural Transm (Vienna). 2018 Apr;125(4):689-698
pubmed: 29299688
Acta Neurol Scand. 2016 Apr;133(4):302-8
pubmed: 26190642
Eur J Clin Invest. 2010 Jan;40(1):35-53
pubmed: 20055895
Medicine (Baltimore). 2015 Nov;94(47):e2125
pubmed: 26632733
Adv Nutr. 2021 Dec 1;12(6):2255-2264
pubmed: 34167149
Neurosci Bull. 2019 Apr;35(2):362-364
pubmed: 30225763
J Pain Res. 2019 Aug 20;12:2529-2536
pubmed: 31686895
Biomed Res Int. 2013;2013:351942
pubmed: 23984350
Headache. 2015 Oct;55(9):1209-17
pubmed: 26283425
Int J Clin Pract. 2014 Oct;68(10):1272-7
pubmed: 24837712
Curr Med Res Opin. 2019 Apr;35(4):715-723
pubmed: 30182753
J Headache Pain. 2020 Feb 24;21(1):22
pubmed: 32093657
Nat Genet. 2022 Feb;54(2):152-160
pubmed: 35115687
Biomed Res Int. 2014;2014:514782
pubmed: 24524078
Nat Commun. 2018 Jan 17;9(1):260
pubmed: 29343764
Cephalalgia. 2004;24 Suppl 1:9-160
pubmed: 14979299
Headache. 2017 Jul;57(7):1118-1135
pubmed: 28699326
Clin Neuropharmacol. 2021 Jan-Feb 01;44(1):5-8
pubmed: 33449474
Iran J Child Neurol. 2020 Fall;14(4):77-86
pubmed: 33193786
Steroids. 2020 Jun;158:108615
pubmed: 32097613
Neurol Sci. 2018 Jun;39(Suppl 1):167-168
pubmed: 29904877